How Much More Do DSOs Pay Than Private Buyers for the Same Dental Practice?
Data Brief
- Published
- May 9, 2026
- Edition
- PPR-DB-2026-V1
- Publisher
- Private Practice Research
- Plain text mirror
- /dso-vs-private-buyer-premium.txt
Suggested citation
Private Practice Research. (2026). How Much More Do DSOs Pay Than Private Buyers for the Same Dental Practice? (Report No. PPR-DB-2026-V1). Private Practice Research. https://privatepracticeresearch.org/reports/dso-vs-private-buyer-premium
Edition: PPR-DB-2026-V1 Status: DRAFT (pre-publish, awaiting operator review) Prepared by: Private Practice Research Editorial Staff. Data Desk. Published: 2026-05-09 Last Updated: 2026-05-01
PPR Methodology Callout This Data Brief synthesizes broker-published transaction multiples and DSO acquisition disclosures to quantify the premium that dental support organizations pay over private (individual-buyer) transactions. Sources include FOCUS Investment Banking, TUSK Practice Sales, McLerran & Associates broker reports, and ADA Health Policy Institute aggregate data on practice ownership. Where multiples are reported as ranges, midpoints are used for comparison and the underlying range is disclosed in-line. This article does not represent a valuation, does not constitute legal or tax advice, and is not affiliated with any DSO or transition broker. Authorship: Private Practice Research editorial staff.
Executive Summary#
Private Practice Research finds that dental support organizations (DSOs) pay roughly 30 to 50 percent more than individual private buyers for the same EBITDA stream, with DSO-eligible transactions clearing 7 to 12 times EBITDA versus 4.5 to 7 times for solo-GP private deals [1][2]. The premium is real but conditional, not universal.
The headline obscures structural variation. Solo general-practice transitions sold to individual dentist-buyers cluster in the mid-single-digit multiple range, constrained by personal financing capacity and bank underwriting standards. Platform-fit acquisitions clear materially higher multiples because institutional capital underwrites to a different model.
Practice size, owner-dependence, geography, and clinical mix all gate access to the higher band. Owners evaluating offers should read DSO multiples as one path within the broader valuation model PPR has documented, not a universal benchmark. For the full taxonomy, see the four-path transition framework at /reports/how-dental-practices-are-valued-2026.
How Big Is the DSO Premium?#
The numerical answer breaks into three tiers, drawn from broker aggregate data covering completed 2024 to 2026 transactions [1][2][3].
- Solo GP, individual private buyer: 4.5 to 5.5 times EBITDA.
- DSO-eligible mid-size group: 6 to 7 times EBITDA, with platform-fit candidates reaching 7.5 to 8 times.
- Large multi-location DSO acquisitions: 7.5 to 9 times EBITDA at the deal level, with platform recapitalizations and strategic combinations reaching 10 to 12 times [1][5].
For an identical EBITDA stream, the multiple-basis premium between a solo private comparable and a platform DSO offer ranges from roughly 30 percent at the lower bound to above 50 percent where strategic fit is strong. Absolute dollar premium scales with practice size, since the same multiple delta applied to a larger earnings base produces a larger spread.
The chart above, drawn from §3.1 of the 2026 Baseline Report at /reports/baseline-2026, displays the multiple distribution by practice tier. The gap between tiers is structural rather than negotiated [5].
Why Do DSOs Pay More?#
Three structural reasons explain the spread, and none of them rely on DSO buyers being irrational or overpaying.
Capital cost. Private equity-backed DSOs deploy committed fund capital with multi-year hold horizons, allowing them to underwrite to longer payback windows. Individual buyers underwrite to personal cash flow and bank financing, which caps the multiple a debt-service-coverage covenant can support [1].
Roll-up arbitrage. A practice acquired at 7 times and folded into a platform that trades at 10 times at recapitalization captures the multiple-arbitrage spread for the platform sponsor. The acquiring DSO shares part of that future spread with the seller at entry because the spread itself is the investment thesis [2].
Strategic value. DSOs pay for fit, not stand-alone earnings alone. Geography density, payer mix, and patient volume that thickens an existing platform all command additional multiple. TUSK's 2025-2026 review describes this as adjacency premium [2].
When Does the DSO Premium Disappear?#
The premium is conditional. Available data suggest four conditions that compress or eliminate it.
- Practices below roughly $1.2M in collections fall under the platform threshold; most institutional DSO buyers will not underwrite them at all [1].
- Heavily owner-dependent practices, where single-provider production exceeds 90 percent of total, trigger a documented 10 to 20 percent haircut even from DSO buyers [1].
- Rural and non-MSA locations face structural exclusion. DSOs concentrate acquisitions in metropolitan statistical areas above 100,000 population [4][5].
- Specialty practices that fall outside the buyer's existing clinical mix do not receive the platform-fit premium and often default to private-comparable pricing.
The Baseline Report documents the owner-dependence effect in §7 Consensus 3 and the metro-rural geographic concentration in §5.2, both available at /reports/baseline-2026 [5].
What This Means for Practice Owners Approaching Transition#
The implication divides cleanly along the platform-fit line. Owners whose practices fall below the DSO platform threshold should benchmark against private-buyer comparables, not headline DSO multiples; quoting the upper band as a target produces unrealistic expectations and prolongs marketing cycles.
Owners whose practices fit DSO criteria face the opposite problem. The single largest variable in their realized multiple is whether the transition is run as a solicited competitive process or a single-buyer negotiation. The marketed-process premium documented by TUSK compounds with the DSO-vs-private spread, meaning competitive marketed-process bidding can add a further increment on top of the structural premium described above [2].
Both paths sit inside how dental practices are valued. The four-path transition framework at /reports/how-dental-practices-are-valued-2026 lays out the decision tree owners use to identify which band applies before soliciting offers.
Frequently Asked Questions#
Do DSOs always pay more than private buyers? No. The premium is conditional on fit. Practices below roughly $1.2M in collections, heavily owner-dependent practices, rural locations, and specialty practices outside the buyer's clinical mix often see the premium compress or disappear entirely [1]. The headline 30 to 50 percent figure applies to platform-fit candidates, not the universe of all transitions.
What EBITDA multiple should a solo GP practice expect from a private buyer in 2026? Mid-range expectations sit at 4.5 to 5.5 times EBITDA based on broker aggregate data covering completed transactions [1][3]. Outliers exist on both sides; practice quality, location, hygiene mix, and lease economics all move the realized multiple within and occasionally outside that band.
What multiple do mid-size group practices clear? Mid-size groups clear 6 to 7 times EBITDA; platform-fit candidates reach 7.5 to 8 times when geography and clinical mix align with an active acquirer [1][2]. The step-up tracks platform-eligibility thresholds rather than gradual scaling.
Why do DSO multiples vary so widely (5 to 12 times)? The variation is definitional. Stand-alone solo deals sold to small DSOs cluster near the bottom; platform-fit roll-ups occupy the middle band; and large multi-location strategic acquisitions and platform recapitalizations sit at the top [1][5]. Quoting a single DSO multiple obscures the tier structure.
Are DSO offers fair? Fair is the wrong frame. DSO offers are competitive within their structural constraints: capital cost, roll-up arbitrage, and strategic fit. Owner-side bargaining power comes from solicitation and preparation, not from challenging the buyer's underwriting model. The evidence is mixed on whether owners realize the full available premium without a marketed process [2].
Limitations#
Multiples reported here are drawn from broker and DSO disclosures, both of which carry selection effects. Only completed transactions enter the data; failed or withdrawn deals are absent. Reported ranges therefore likely overstate the central tendency for the marketed universe.
DSO definitional ambiguity also shifts the range. Formal DSOs, invisible DSOs (IDSOs), and partnership structures use different earnings definitions, working-capital adjustments, and rollover-equity conventions, all of which change the headline multiple without changing the economic value transferred [1][2].
Sources#
[1] FOCUS Investment Banking, "2026 Dental Industry Update," 2026. [2] TUSK Practice Sales, "Q2 2026 Dental Market Report" and "2025 Market Review & 2026 Outlook," 2025-2026. [3] McLerran & Associates broker aggregate transaction data, 2024-2026. [4] ADA Health Policy Institute, "Supply of Dentists" series, 2024-2025. [5] Private Practice Research, "The State of Dental Practice Values: 2026 Baseline Report," PPR Edition PPR-BASELINE-2026-V1.